Save your place

Sign in to WhoBought

Please try again later.

DiaMedica Therapeutics Inc. (DMAC) institutional ownership

Latest close $7.01 Jul 20, 2026
Market cap$177M 52-week range SectorHealthcare
Funds holding · Q1 2026
80
reported DMAC position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
44 buyers · 36 sellers

DiaMedica Therapeutics Inc. (DMAC) price and institutional activity

Dates

Q1 2026

$0 bought by 44 investors
Millennium Management LLCOsaic Holdings, Inc. +42 more
$0 sold by 36 investors
Morgan StanleyWellington Management Group LLP +34 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

DiaMedica Therapeutics Inc. (DMAC) institutional activity · 80

Investor Type Est. change Change Δ Own Date
Morgan Stanley · Reduced
Change −442K Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −442K Q1 2026
Millennium Management LLC · Added
Change +167K Date Q1 2026
Millennium Management LLC Added· Q1 2026 +167K Q1 2026
Wellington Management Group LLP · Exited
Change −104K Δ Own −100.0% Date Q1 2026
Wellington Management Group LLP Exited· Q1 2026 −104K −100.0% Q1 2026
Fred Alger Management, LLC · Exited
Change −83K Δ Own −100.0% Date Q1 2026
Fred Alger Management, LLC Exited· Q1 2026 −83K −100.0% Q1 2026
Osaic Holdings, Inc. · Added
Change +73K Date Q1 2026
Osaic Holdings, Inc. Added· Q1 2026 +73K Q1 2026
Goldman Sachs Group Inc · Reduced
Change −70K Date Q1 2026
Goldman Sachs Group Inc Reduced· Q1 2026 −70K Q1 2026
Exoduspoint Capital Management, LP · New
Change +60K Date Q1 2026
Exoduspoint Capital Management, LP New· Q1 2026 +60K Q1 2026
Corient Ia LLC · New
Change +60K Date Q1 2026
Corient Ia LLC New· Q1 2026 +60K Q1 2026
Renaissance Technologies LLC New· Q1 2026 +53K Q1 2026
First Manhattan Co. LLC. · Added
Change +50K Date Q1 2026
First Manhattan Co. LLC. Added· Q1 2026 +50K Q1 2026
Barclays PLC · Reduced
Change −46K Date Q1 2026
Barclays PLC Reduced· Q1 2026 −46K Q1 2026
BlackRock · Reduced
Change −45K Date Q1 2026
BlackRock Reduced· Q1 2026 −45K Q1 2026
Gsa Capital Partners LLP · Added
Change +45K Date Q1 2026
Gsa Capital Partners LLP Added· Q1 2026 +45K Q1 2026
Awm Investment Company, Inc. · New
Change +36K Date Q1 2026
Awm Investment Company, Inc. New· Q1 2026 +36K Q1 2026
Citadel Advisors LLC Added· Q1 2026 +35K +31.6% Q1 2026
Data through Q1 2026 · filed May 21, 2026
15 of 80

Famous investor activity in DiaMedica Therapeutics Inc. (DMAC)

DiaMedica Therapeutics Inc. (DMAC) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Giuffre Randall Michael · Director Grant (A) 40K
Owned 40K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Giuffre Randall Michael Director Grant (A) 40K 40K Jun 1, 2026 Jun 3, 2026
Kuntz Richard · Director Grant (A) 40K
Owned 40K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Kuntz Richard Director Grant (A) 40K 40K Jun 1, 2026 Jun 3, 2026
O'Connor Daniel J. · Director Grant (A) 40K
Owned 40K Trade date Jun 1, 2026 Filed date Jun 3, 2026
O'Connor Daniel J. Director Grant (A) 40K 40K Jun 1, 2026 Jun 3, 2026
Lewis Tanya · Director Grant (A) 40K
Owned 40K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Lewis Tanya Director Grant (A) 40K 40K Jun 1, 2026 Jun 3, 2026
Semba Charles Pauling · Director Grant (A) 40K
Owned 40K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Semba Charles Pauling Director Grant (A) 40K 40K Jun 1, 2026 Jun 3, 2026
Parsons James T. · Director Grant (A) 51K
Owned 51K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Parsons James T. Director Grant (A) 51K 51K Jun 1, 2026 Jun 3, 2026
Pauls Dietrich John · Director Grant (A) 380K
Owned 380K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Pauls Dietrich John Director Grant (A) 380K 380K Jun 1, 2026 Jun 3, 2026
Kellen Scott · Officer Grant (A) 162K
Owned 162K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Kellen Scott Officer Grant (A) 162K 162K Jun 1, 2026 Jun 3, 2026
Krop Julie · Officer Grant (A) 68K
Owned 68K Trade date Jun 1, 2026 Filed date Jun 3, 2026
Krop Julie Officer Grant (A) 68K 68K Jun 1, 2026 Jun 3, 2026
Parsons James T. · Director Grant (A) $85K
Price $8.42 Qty 10K Owned 98K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Parsons James T. Director Grant (A) $8.42 10K $85K 98K Jan 2, 2026 Jan 6, 2026
Giuffre Randall Michael · Director Grant (A) $52K
Price $8.42 Qty 6K Owned 399K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Giuffre Randall Michael Director Grant (A) $8.42 6K $52K 399K Jan 2, 2026 Jan 6, 2026
Semba Charles Pauling · Director Grant (A) $28K
Price $8.42 Qty 3K Owned 48K Trade date Jan 2, 2026 Filed date Jan 6, 2026
Semba Charles Pauling Director Grant (A) $8.42 3K $28K 48K Jan 2, 2026 Jan 6, 2026
Trill AB · 10% Owner Buy +$626K
Price $8.57 Qty +73K Owned 8.8M Trade date Nov 25, 2025 Filed date Dec 8, 2025
Trill AB 10% Owner Buy $8.57 +73K +$626K 8.8M Nov 25, 2025 Dec 8, 2025
Trill AB · 10% Owner Buy +$318K
Price $7.89 Qty +40K Owned 8.8M Trade date Nov 24, 2025 Filed date Dec 8, 2025
Trill AB 10% Owner Buy $7.89 +40K +$318K 8.8M Nov 24, 2025 Dec 8, 2025
Trill AB · 10% Owner Buy +$1.5M
Price $7.41 Qty +209K Owned 8.7M Trade date Nov 21, 2025 Filed date Dec 8, 2025
Trill AB 10% Owner Buy $7.41 +209K +$1.5M 8.7M Nov 21, 2025 Dec 8, 2025
15 of 33
15 of 33 Sign in to continue to older insider transactions.

DiaMedica Therapeutics Inc. (DMAC) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Jacinto Richard II 4.6M
% of shares outstanding 12.0% Filing date Jun 23, 2023
Jacinto Richard II 4.6M 12.0% Jun 23, 2023
Tomeqt Private AB 2.9M
% of shares outstanding 10.8% Filing date Dec 6, 2022
Tomeqt Private AB 2.9M 10.8% Dec 6, 2022
Trill AB 4.0M
% of shares outstanding 10.6% Filing date Jun 27, 2023
Trill AB 4.0M 10.6% Jun 27, 2023
Dialectic Capital Management, LP 2.2M
% of shares outstanding 5.1% Filing date Jul 8, 2024
Dialectic Capital Management, LP 2.2M 5.1% Jul 8, 2024
Stonepine Capital Management, LLC 1.2M
% of shares outstanding 4.5% Filing date Feb 11, 2022
Stonepine Capital Management, LLC 1.2M 4.5% Feb 11, 2022
Lytton Laurence W 1.1M
% of shares outstanding 4.1% Filing date Feb 15, 2022
Lytton Laurence W 1.1M 4.1% Feb 15, 2022
Lynch Timothy P 100K
% of shares outstanding 0.4% Filing date Feb 13, 2023
Lynch Timothy P 100K 0.4% Feb 13, 2023
Tomenterprise AB
% of shares outstanding 0.0% Filing date Jun 27, 2023
Tomenterprise AB 0.0% Jun 27, 2023
8 of 8

DiaMedica Therapeutics Inc. (DMAC) ownership FAQ

Who owns DMAC?

80 reporting institutions disclosed DMAC position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.